Daymark Health Raises $20M in Series A Funding to Scale Tech-Enabled Cancer Care Platform to Thousands of Patients

Investment led by Healthier Capital with Blue Venture Fund allows Daymark to continue supporting patients with cancer

PHILADELPHIA, Sept. 25, 2025 /PRNewswire/ -- Daymark Health, the company redefining the cancer care experience for patients, providers, and health plans, today announced a $20 million Series A funding round led by Healthier Capital with Blue Venture Fund, with participation from existing investors including Yosemite, Maverick Ventures, and Oncology Ventures.

Daymark delivers care to patients that addresses their clinical, social, and mental health needs both virtually and in the home, in collaboration with oncologists and primary care providers. The company's comprehensive, tech-enabled cancer care platform and team of community-based clinicians provides patients with care navigation, 24/7 support, mental health assistance, symptom management, and social support. Daymark partners directly with health plans to align incentives to improve patient outcomes and manage the total cost of care.

"We are seeing a tipping point in oncology, where payers feel the ongoing pressures of managing specialty risk and providers are seeking solutions that put patients first," said Dr. Justin Bekelman, oncologist and CEO and Co-Founder of Daymark Health. "We built Daymark Health to provide compassionate, intelligent, and frictionless cancer care at scale and are honored to partner with our new investors to advance cancer care across the U.S."

Daymark Health's $20 million financial investment from Healthier Capital and Blue Venture Fund will allow the company to continue scaling its cancer care platform, forging new partnerships with health plans and providers across the country and bringing its innovative technology platform to more patients.

Healthier Capital partners with technology-powered innovators to deliver healthier outcomes for all, and was founded by Amir Dan Rubin, former CEO of One Medical, the tech-enabled primary care organization which is now part of Amazon. Blue Venture Fund is a unique collaboration among Blue Cross and Blue Shield (BCBS) companies, the Blue Cross Blue Shield Association, and Sandbox, to which 36 BCBS companies and special purpose licensees have committed over $1.2 billion across five funds. The investment from these organizations underscores the industry-wide recognition that oncology is entering a period of rapid change, with payers and providers aligned on the need for more integrated, sustainable models of care. The company will add Healthier Capital's Dr. Aman Mahajan and Blue Venture Fund's Kelsey Maguire to its board.

"Daymark is breaking down the silos in healthcare delivery to better enable personalized care for patients with cancer, while improving outcomes and reducing avoidable costs," said Aman Mahajan, MD, PhD, Partner at Healthier Capital. "Daymark is delivering a transformational model of personalized, high-quality, value-based cancer care."

"Daymark and Blue Venture Fund are passionate about a shared purpose: to give all patients the best possible care experience, driving better health outcomes and ensuring they feel seen, heard, and valued," said Kelsey Maguire, Managing Director at the Blue Venture Fund. "We're thrilled to partner with Daymark as they redefine the cancer care experience and evolve what's possible in value-based oncology."

To learn more about Daymark Health, please visit www.daymarkhealth.com.

About Daymark Health
Daymark Health is a cancer care company that partners with health plans to provide in-home and virtual supportive and wraparound care to patients with cancer in collaboration with their own oncologists. Daymark's supportive, personalized cancer care program empowers patients with care navigation, 24/7 support, mental health assistance, symptom management, and social support – all delivered virtually and in the home. For more information, visit www.daymarkhealth.com.

SOURCE Daymark Health